ABT1 modifies SMARD1 pathology via interactions with IGHMBP2 and stimulation of ATPase and helicase activity.

JCI Insight · 2023 · PMC9977310 · PMID 36480289

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Throughout the 19 days of assessment, Ighmbp2 nmd/nmd + scAAV9- Abt1 (4 × 10 11 ) animals trended to have better HLS then Ighmbp2 nmd/nmd animals, but because of the variation within each group, the deviation did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.